ResearcherSapienza University of RomeActive in the last 2 years
Emanuela Anastasi
Matched on ORCID iD 0000-0002-5124-3219; OpenAlex author ID A5058534895. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 6)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 4
2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 3 papers · 2025: 2 papers
Papers 7
- Establishing a Decision-Making Threshold for PIVKA II in the Diagnosis of Pancreatic Ductal Adenocarcinoma (PDAC): A Single Centre Experience. Last author DOI 10.31557/apjcp.2025.26.10.3603↗
- Differential Associations of PIVKA-II with Epithelial and Mesenchymal Features in HCC and PDAC. Last author DOI 10.3390/ijms26157581↗
- Emerging horizons on molecular and circulating biomarkers in pancreatic adenocarcinoma. Last author DOI 10.3389/fonc.2024.1483306↗
- Combined PIVKA II and Vimentin-Guided EMT Tracking in Pancreatic Adenocarcinoma Combined Biomarker-Guided EMT Tracking in PDAC. Last author DOI 10.3390/cancers16132362↗
- PANC-1 Cell Line as an Experimental Model for Characterizing PIVKA-II Production, Distribution, and Molecular Mechanisms Leading to Protein Release in PDAC. Last author DOI 10.3390/ijms25063498↗
- PIVKA-II: A biomarker for diagnosing and monitoring patients with pancreatic adenocarcinoma. Last author DOI 10.1371/journal.pone.0251656↗
- Protein Induced by Vitamin K Absence II (PIVKA-II) as a potential serological biomarker in pancreatic cancer: a pilot study. Co-author DOI 10.11613/bm.2019.020707↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Antonella Farina · 5 shared papers, 2024–2025 · strength 1.41
- Paper Emerging horizons on molecular and circulating biomarkers in pancreatic adenocarcinoma. DOI 10.3389/fonc.2024.1483306↗
- Paper Establishing a Decision-Making Threshold for PIVKA II in the Diagnosis of Pancreatic Ductal Adenocarcinoma (PDAC): A Si… DOI 10.31557/apjcp.2025.26.10.3603↗
- Paper Differential Associations of PIVKA-II with Epithelial and Mesenchymal Features in HCC and PDAC. DOI 10.3390/ijms26157581↗
- Sara Tartaglione · 5 shared papers, 2019–2025 · strength 1.06
- Paper Establishing a Decision-Making Threshold for PIVKA II in the Diagnosis of Pancreatic Ductal Adenocarcinoma (PDAC): A Si… DOI 10.31557/apjcp.2025.26.10.3603↗
- Paper PANC-1 Cell Line as an Experimental Model for Characterizing PIVKA-II Production, Distribution, and Molecular Mechanism… DOI 10.3390/ijms25063498↗
- Paper Combined PIVKA II and Vimentin-Guided EMT Tracking in Pancreatic Adenocarcinoma Combined Biomarker-Guided EMT Tracking … DOI 10.3390/cancers16132362↗
- Marta Moretti · 2 shared papers, 2024 · strength 0.55
- Irene Pecorella · 1 shared paper, 2019 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.